Comparative study of transfer factor and acyclovir in the treatment of herpes zoster

International Journal of Immunopharmacology

Volumn 20, Issue 10, 1998, Pages 521-535

  Estrada Parra, S ^a   Nagaya, A ^a   Serrano, E ^a   Rodriguez, O ^a   Santamaria, V ^a   Ondarza, R ^a   Chavez, R ^a   Correa, B ^a   Monges, A ^a   Cabezas, R ^a   Calva, C ^a   Estrada Garcia, I ^a  

^a NONE

Author keywords

Herpes zoster treatment; IFN ; Transfer factor

Indexed keywords

ACICLOVIR; CD4 ANTIGEN; GAMMA INTERFERON; TRANSFER FACTOR;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DOUBLE BLIND PROCEDURE; FEMALE; HERPES ZOSTER; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOMODULATION; LABORATORY TEST; LYMPHOCYTE COUNT; MALE; ORAL DRUG ADMINISTRATION; PAIN ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; ROSETTE FORMATION; T LYMPHOCYTE;

ACYCLOVIR; ANTIVIRAL AGENTS; CD4-CD8 RATIO; DOUBLE-BLIND METHOD; FEMALE; HERPES ZOSTER; HERPESVIRUS 3, HUMAN; HUMANS; INTERFERON TYPE II; MALE; T-LYMPHOCYTES; TRANSFER FACTOR;

EID: 0031767956     PISSN: 01920561     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0192-0561(98)00031-9     Document Type: Article

References (33)

1. Arvin A. M. J. Infect. Dis. 35:1992;41.
2. Balfour H. H. Jr. J. Med. Virol. 1:1993;4-81.
3. Berger R., Florent G., Just M. Infect. Immun. 32:1981;24-27.
4. Cabezas-Quiroga, R., Estrada-Parra, S., Abdo-Rodríguez, A., Selmain-Housein, M., Sosa, S., Chávez-Sánchez, F. R., Estrada-García, I., Berrón-Pérez, R., Fernández-Ortega, C., Herrera-Roja, A., and Araña-Rosainz, J. (1996). Inmunoterapia con factor de transferencia. Centro de Investigación Médico Quirúrgicas, Centro de Investigaciones Biológicas, Cuba y Escuela Nacional de Ciencias. Biológicas, IPN.
5. Cabezas-Quiroga R., Estrada-Parra S., Padierna L., Fernández C., López P. Biotecnol. Aplicada. 7:1990;52-56.
6. Cohen P. R. Dermatol. Clin. 12:1994;51-68.
7. Díaz P. S., Smith S., Hunter E., Arvin A. M. J. Immunol. 142:1989;636-641.
8. Estrada-Parra S., Velasco-Castrejón O., Rébora F., Díaz M. L., Padierna J. Salud Pública Mex. 25:1983;280-290.
9. Fudenberg H., Pizza G. Progress in Drug Research. 4:1993;311-356.
10. Fudenberg H. H., Fudenberg H. Annu. Rev. Pharmacol. Toxicol. 29:1989;475-526.
11. Hayward A. R., Pontesilli M., Herberger M., Laszlo M., Levin M. J. Virol. 58:1986;179-184.
12. Higa K., Noda B., Manabe H., Sato S., Dan K. Pain. 51:1992;111-118.
13. Hope-Simpson R. E. Proc. R. Soc. Med. 58:1965;9-20.
14. Huskisso, E. C. Visual analogue scales. Pain measurement and assessment. Edited by Ronald Melzack, Raven Press, New York 1983.
15. Institute of Medicine. New Vaccine Development. Vol I., 1995. Diseases of importance in the United States. Appendix J. Prospects for immunizing against herpesvirus varicellae. Washington, DC: National Academy Press. 28-58.
16. Joclick, W. K. (1990). Interferons. In Fields, B. N, Knip, D. M., (Eds), Virology. Raven Press: New York.
17. Kamiya H., Ihara T., Hattori A., Iwasa T., Sakurai M., Izawa T., Yamada A., Takahashi M. J. Infect. Dis. 136:1977;784-788.
18. Kirkpatrick C. H. Ann. N.Y. Acad. Sci. 685:1993;362-367.
19. Lawrence H. S. J. Clin. Inv. 34:1955;219-210.
20. Leszczyszyn-Pynka M. Acta Haematol. Pol. 26:1995;393-402.
21. Levin M. J. J. Med. Virol. 1:1993;158-164.
22. Mazur M. H., Dolin R. Am. J. Med. 65:1978;738-744.
23. Meier J. F., Straus S. E. J. Infect. Dis. 13:1992;23.
24. Miller A. E. Neurology. 30:1980;582-587.
25. Pizza G., De Vinci C., Fudenberg H. Progr. Drug. Res. 42:1994;402-417.
26. Ragozzino M. W., Melton L. J. III, Kurland L.T., Chu C.P., Perry H. O. Medicine (Baltimore). 61:1982;310-316.
27. Rozzo S. J., Kirkpatrick C. Mol. Immunol. 29:1992;167-182.
28. Saibara T., Maeda T., Onishi S., Yamamoto Y. J. Med. Virol. 39:1993;242-245.
29. Steele R. W., Myers M. G., Vincent M. M. N. Eng. J. Med. 303:1980;355-359.
30. Sudhir K. S., Sizemore R. S., Gottlieb A. A. Biothechnol. 6:1988;810-815.
31. Wardlaw, A. C. (1985). Practical statistics for experimental biologists. John Wiley and Sons. Chichester, U.K.
32. Weller T. H. J. Infect Dis. 1:1992;6.
33. Withley R. J. J. Infect. Dis. 51:1992;57.